Asciminib RMP Study

Clinical trial NCT05943522 · RECRUITING

Trial details

NCT number: NCT05943522
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia

Start date: 2023-07-19
Primary completion: 2030-06-07
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.